Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study

Fig. 4

Silencing of Ctr1 and uptake of platinum compounds. a Expression of Ctr1 protein was monitored in A2780 and A2780cisR cells. b Silencing of Ctr1 gene in A2780 with percentage of decrease in Ctr1 protein levels. c Cisplatin uptake into A2780, A2780cisR and A2780 Ctr1− (# 348) cells. d Uptake of Cisplatin (IV) derivatives (RJY6 and RJY13) into A2780, A2780cisR and A2780 Ctr1− (# 348) cells. P values; * P < 0.05 and **P < 0.005

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us